남성호르몬 보충요법에 의해 유발된 적혈구증가증: 장기지속형 주사형 테스토스테론 제제의 합병증Polycythemia as a Complication of Long-acting Injectable Testosterone Undecanoate
- Other Titles
- Polycythemia as a Complication of Long-acting Injectable Testosterone Undecanoate
- Authors
- 신동식; 고기원; 남상간; 진명헌; 김제종; 문두건
- Issue Date
- 2008
- Publisher
- 대한남성과학회
- Keywords
- Erythrocytosis; Polycythemia; Testosterone; Erythrocytosis; Polycythemia; Testosterone
- Citation
- The World Journal of Men's Health, v.26, no.4, pp.237 - 239
- Indexed
- KCI
OTHER
- Journal Title
- The World Journal of Men's Health
- Volume
- 26
- Number
- 4
- Start Page
- 237
- End Page
- 239
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/125185
- ISSN
- 2287-4208
- Abstract
- Polycythemia is a condition in which the red blood cell count is increased due to an inherited or acquired mutation, a physiologic response to hypoxia, autonomous erythropoietin production, or deliberate erythropoietin administration. Higher testosterone levels appear to act as a stimulus for erythropoiesis and testosterone replacement therapies have rarely been reported as causes of polycythemia. We report here a case of a 51-year-old man with polycythemia that was caused by long-acting testosterone undecanoate (NebidoⓇ).
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.